Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium ...

Kaminski and his colleagues were pioneers in applying high-throughput, genome-scale transcript profiling to advanced lung ...

In a conversation with Managed Healthcare Executive, 10XBeta CEO Marcel Botha warned that proposed Medicaid cuts, combined ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The latest report by Urban Institute warns that proposed Medicaid funding cuts could cost states like California, New York, ...

Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...